- Ford Motor (2001, 22 млн автомобилей, дефект в системе зажигания);
- Volkswagen (2015, 8,5 млн автомобилей, ПО с «экологическим дефектом», афера концерна Volkswagen);
- Также АвтоВАЗ#Отзыв продукции.
- Research could expand engineered T-cell cancer treatment. MedicalXpress
- Jang Hwan Cho, James J. Collins, Wilson W. Wong (2018). Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses. Cell, 173(6), 1426–1438.e11, doi:10.1016/j.cell.2018.03.038
- O’Rourke, D. M., Nasrallah, M. P., Desai, A., Melenhorst, J. J., Mansfield, K., Morrissette, J. J., … & Isaacs, R. (2017). A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science Translational Medicine, 9(399), eaaa0984.
doi:10.1126/scitranslmed.aaa0984 - Could CAR-T treatments work in glioblastoma?
- Карл Джун, Брюс Левин, Эвери Пози
Убийцы рака // В мире науки. — 2017. — № 5-6. — С. 32 — 37. - Scientists engineer immune cells to protect organs from transplant rejection. ScienceDaily, April 2016
- Celyad issues a White Paper about CAR T NKR-2 current knowledge and differences with classical CAR-T technologies
- Preclinical studies: CAR-T NKR-2 well-defined and multiple mechanisms of action
- Ye Li, David L. Hermanson, Branden S. Moriarity, Dan S. Kaufman (2018). Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. Cell Stem Cell. doi:10.1016/j.stem.2018.06.002
- Chimeric antigen receptor macrophages (CARMA)
- Engineering non-immune cells to kill cancer cells. ScienceDaily, 13 November 2017
- Kojima R, Scheller L, Fussenegger M. (2017). Nonimmune cells equipped with T-cell-receptorlike signaling for cancer cell ablation. Nature Chemical Biology, doi:10.1038/nchembio.2498
- Cancer Immunotherapies May Deploy Nonimmune Cells Engineered to a «T». GEN. Nov. 14, 2017
- Montel-Hagen, A., Seet, C. S., Li, S., Chick, B., Zhu, Y., Chang, P., … & He, C. (2019). Organoid-induced differentiation of conventional T cells from human pluripotent stem cells. Cell stem cell, 24(3), 376-389. doi:10.1016/j.stem.2018.12.011 PMC 6687310
- UCLA scientists create a renewable source of cancer-fighting T cells
Источник:
